Beone Medicines Ltd (ONC) - News Archive

In a significant advancement in cancer treatment, the U.S. Food and Drug Administration (FDA) has approved TEVIMBRA (tebotelimab) for the first-line treatment of advanced esophageal squamous cell carcinoma (ESCC) in com...

SAN MATEO, California In a significant advancement for cancer treatment, the U.S. Food and Drug Administration (FDA) has granted approval for TEVIMBRA (tislelizumab-jsgr) as a first-line therapy in combination with plat...

BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology-focused biopharmaceutical company based in San Mateo, California, has announced its financial results for the fourth quarter and the entire year o...

In a striking announcement from its San Mateo headquarters, BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235) has disclosed its financial results for both the fourth quarter and the entirety of 2024, showcasing a po...